Mission Hospital is the first in California and among a select few in the world to offer, a revolutionary, noninvasive treatment for malignant and benign liver tumors. The procedure works by using high-energy ultrasound waves that convert to sonic beams and destroy liver tumors without a single incision.

Because the innovative procedure is noninvasive, it minimizes the risk of infection, bleeding and other complications. can be used to effectively treat liver tumors in patients who are not candidates for open surgery or have been told their liver tumor is inoperable. The procedure is compatible with chemotherapy and/or radiation therapy and can also be used to treat metastatic cancer that has spread to the liver.

During the procedure, targeted ultrasound waves form bubble clouds that implode and collapse rapidly, destroying only tumor cells. After tumors are liquefied by the sonic beam, only tiny molecules remain in the body. These microscopic fragments are too small to allow the cancer to spread and regrow.

SARS-CoV-2 breakthrough infections in previously vaccinated individuals are characterized by reduced activation of innate immune responses.

The immune system is a marathon, not a sprint.

New research reveals stem-like T cells that help fight disease longer—a breakthrough for cancer treatments and vaccines. Discover more via Pursuit → unimelb.me/3EnoujK

---

It’s a reminder that, much like training for a race, scientific discovery demands persistence, teamwork and a clear goal.

While more work is needed to translate these findings into real-world applications, harnessing the unique strengths of stem-like T cells and their regulation paves the way for innovative treatments that could redefine how we tackle chronic diseases and cancer.

This study is a collaborative effort between the Doherty Institute, the Peter MacCallum Cancer Centre, La Trobe University, Northwestern University (USA), the Olivia Newton-John Cancer Research Institute, the University of Birmingham (UK) and the University of Melbourne.